Format
Sort by

Send to

Choose Destination

Links from PubChem BioAssay

Items: 1 to 20 of 26

1.

Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Wilensky RL, Macphee CH.

Curr Opin Lipidol. 2009 Oct;20(5):415-20. doi: 10.1097/MOL.0b013e3283307c16. Review.

PMID:
19667981
2.

Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.

Bachovchin DA, Brown SJ, Rosen H, Cravatt BF.

Nat Biotechnol. 2009 Apr;27(4):387-94. doi: 10.1038/nbt.1531. Erratum in: Nat Biotechnol. 2009 May;27(5):485.

3.
4.

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.

Anderson JL.

Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Review.

PMID:
18549868
5.

Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.

Kono N, Inoue T, Yoshida Y, Sato H, Matsusue T, Itabe H, Niki E, Aoki J, Arai H.

J Biol Chem. 2008 Jan 18;283(3):1628-36.

6.

Oxidized phospholipids: from molecular properties to disease.

Fruhwirth GO, Loidl A, Hermetter A.

Biochim Biophys Acta. 2007 Jul;1772(7):718-36. Review.

7.

Plasma PAF-acetylhydrolase: an unfulfilled promise?

Karabina SA, Ninio E.

Biochim Biophys Acta. 2006 Nov;1761(11):1351-8. Review.

PMID:
16807087
8.

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Leitinger N.

Mol Nutr Food Res. 2005 Nov;49(11):1063-71. Review.

PMID:
16270279
10.

Discovering potent and selective reversible inhibitors of enzymes in complex proteomes.

Leung D, Hardouin C, Boger DL, Cravatt BF.

Nat Biotechnol. 2003 Jun;21(6):687-91.

PMID:
12740587
11.

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress.

Uchida K.

Prog Lipid Res. 2003 Jul;42(4):318-43. Review.

PMID:
12689622
12.

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.

Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70.

PMID:
12643913
13.

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

Karasawa K, Harada A, Satoh N, Inoue K, Setaka M.

Prog Lipid Res. 2003 Mar;42(2):93-114. Review.

PMID:
12547653
14.

Identification of platelet-activating factor acetylhydrolase II in human skin.

Marques M, Pei Y, Southall MD, Johnston JM, Arai H, Aoki J, Inoue T, Seltmann H, Zouboulis CC, Travers JB.

J Invest Dermatol. 2002 Oct;119(4):913-9.

15.

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness.

Jessani N, Liu Y, Humphrey M, Cravatt BF.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10335-40.

16.

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.

Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM.

Crit Care Med. 2002 May;30(5 Suppl):S294-301. Review.

PMID:
12004251
17.

Phospholipase A(2)s and lipid peroxidation.

Nigam S, Schewe T.

Biochim Biophys Acta. 2000 Oct 31;1488(1-2):167-81. Review.

PMID:
11080686
18.

Platelet-activating factor and related lipid mediators.

Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM.

Annu Rev Biochem. 2000;69:419-45. Review.

PMID:
10966465
19.

Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II.

Matsuzawa A, Hattori K, Aoki J, Arai H, Inoue K.

J Biol Chem. 1997 Dec 19;272(51):32315-20.

20.
Items per page

Supplemental Content

Support Center